RCKT
Price:
$3.35
Market Cap:
$365.80M
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs. It is currently progressing three ex vivo lentiviral vector therapies aimed at specific genetic conditions: Fanconi anemia, characterized by a bone marrow defect that hinders blood cell production; leukocyte adhesion deficiency-I, an inherited disorder resulting in a compromised immune system; and pyruvate kinase deficiency, a rare autosomal recessive red blood cell ailment leading to chronic non-spherocytic hemolytic anemia. C...[Read more]
Industry
Biotechnology
IPO Date
2015-02-18
Stock Exchange
NASDAQ
Ticker
RCKT
According to Rocket Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -70.79%. This represents a change of 299.70% compared to the average of -17.71% of the last 4 quarters.
The mean historical ROE of Rocket Pharmaceuticals, Inc. over the last ten years is -48.36%. The current -70.79% ROE has changed 46.37% with respect to the historical average. Over the past ten years (40 quarters), RCKT's ROE was at its highest in in the December 2019 quarter at -6.46%. The ROE was at its lowest in in the September 2024 quarter at -20.23%.
Average
-48.36%
Median
-47.58%
Minimum
-80.49%
Maximum
-27.08%
Discovering the peaks and valleys of Rocket Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 44.09%
Maximum Annual ROE = -27.08%
Minimum Annual Increase = -37.81%
Minimum Annual ROE = -80.49%
| Year | ROE | Change |
|---|---|---|
| 2025 | -80.49% | 44.09% |
| 2024 | -55.86% | 12.03% |
| 2023 | -49.86% | 10.05% |
| 2022 | -45.31% | 21.86% |
| 2021 | -37.18% | 27.64% |
| 2020 | -29.13% | 7.55% |
| 2019 | -27.08% | -29.48% |
| 2018 | -38.40% | -37.81% |
| 2017 | -61.76% | 5.44% |
| 2016 | -58.57% | -6.25% |
The current ROE of Rocket Pharmaceuticals, Inc. (RCKT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-62.07%
5-year avg
-53.74%
10-year avg
-48.36%
Rocket Pharmaceuticals, Inc.’s ROE is greater than LB Pharmaceuticals Inc Common Stock (-17.68%), greater than Aura Biosciences, Inc. (-78.12%), greater than Solid Biosciences Inc. (-74.45%), greater than Autolus Therapeutics plc (-128.53%), greater than Design Therapeutics, Inc. (-33.07%), greater than Annexon, Inc. (-101.19%), less than Galectin Therapeutics Inc. (21.05%), less than I-Mab (-0.50%), greater than Quantum-Si incorporated (-47.35%), greater than DBV Technologies S.A. (-130.06%),
| Company | ROE | Market cap |
|---|---|---|
| -17.68% | $860.30M | |
| -78.12% | $407.03M | |
| -74.45% | $648.99M | |
| -128.53% | $401.88M | |
| -33.07% | $776.96M | |
| -101.19% | $586.02M | |
| 21.05% | $186.05M | |
| -0.50% | $542.01M | |
| -47.35% | $197.62M | |
| -130.06% | $371.50M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rocket Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rocket Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Rocket Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Rocket Pharmaceuticals, Inc. (RCKT)?
What is the highest ROE for Rocket Pharmaceuticals, Inc. (RCKT)?
What is the 3-year average ROE for Rocket Pharmaceuticals, Inc. (RCKT)?
What is the 5-year average ROE for Rocket Pharmaceuticals, Inc. (RCKT)?
How does the current ROE for Rocket Pharmaceuticals, Inc. (RCKT) compare to its historical average?